Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis

NCT03650712 is registered in ClinicalTrials.gov with Katie Larson Ode as lead sponsor.

NCT NCT03650712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03650712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis
Lead sponsor
Katie Larson Ode
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2019
Completion date
August 31, 2023
Enrollment
317 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis-related diabetes